Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,051 | 612 | 99.7% |
| Education | $32.62 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,394 | 125 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,960 | 121 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,620 | 81 | $0 (2024) |
| Grifols USA, LLC | $613.05 | 26 | $0 (2024) |
| Amgen Inc. | $451.85 | 24 | $0 (2024) |
| Gilead Sciences, Inc. | $380.80 | 20 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $362.88 | 17 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $346.62 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $346.34 | 17 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $291.16 | 18 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,582 | 65 | AstraZeneca Pharmaceuticals LP ($462.35) |
| 2023 | $2,147 | 96 | AstraZeneca Pharmaceuticals LP ($455.83) |
| 2022 | $1,886 | 87 | GlaxoSmithKline, LLC. ($355.04) |
| 2021 | $1,114 | 56 | Boehringer Ingelheim Pharmaceuticals, Inc. ($210.30) |
| 2020 | $833.74 | 46 | AstraZeneca Pharmaceuticals LP ($147.06) |
| 2019 | $1,687 | 101 | AstraZeneca Pharmaceuticals LP ($370.79) |
| 2018 | $1,416 | 82 | AstraZeneca Pharmaceuticals LP ($339.45) |
| 2017 | $1,418 | 82 | AstraZeneca Pharmaceuticals LP ($267.45) |
All Payment Transactions
615 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $28.29 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: Pulmonology | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.31 | General |
| Category: RESPIRATORY | ||||||
| 09/23/2024 | Pulmonx Corporation | ZEPHYR DELIVERY CATHETER (Device), PULMONX CHARTIS TABLET CONSOLE, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: PULMONOLOGY | ||||||
| 09/19/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Inflammation | ||||||
| 09/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: Respiratory | ||||||
| 08/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: RESPIRATORY | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Respiratory | ||||||
| 07/23/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: NEUROLOGY | ||||||
| 07/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: RESPIRATORY | ||||||
| 07/08/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Inflammation | ||||||
| 07/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: RESPIRATORY | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Respiratory | ||||||
| 06/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: RESPIRATORY | ||||||
| 06/11/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $30.30 | General |
| Category: Respiratory | ||||||
| 06/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $34.91 | General |
| Category: RESPIRATORY | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Respiratory | ||||||
| 05/17/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: Pulmonology | ||||||
| 05/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: IMMUNOLOGY | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Respiratory | ||||||
| 05/13/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $26.64 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/09/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,318 | 2,794 | $920,790 | $257,464 |
| 2022 | 11 | 1,330 | 2,744 | $915,145 | $259,383 |
| 2021 | 14 | 1,656 | 3,266 | $591,690 | $310,938 |
| 2020 | 13 | 1,528 | 3,209 | $530,790 | $277,349 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 359 | 810 | $202,500 | $87,111 | 43.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 305 | 1,159 | $330,315 | $76,706 | 23.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 270 | 308 | $201,600 | $44,752 | 22.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 93 | 216 | $81,000 | $21,533 | 26.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 106 | 106 | $53,000 | $19,632 | 37.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 30 | 36 | $16,200 | $3,479 | 21.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 39 | 39 | $5,850 | $948.09 | 16.2% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 43 | 47 | $9,400 | $822.50 | 8.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 14 | 14 | $3,500 | $731.50 | 20.9% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 14 | 14 | $7,000 | $556.08 | 7.9% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 18 | 18 | $6,660 | $527.94 | 7.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 13 | 13 | $2,925 | $456.82 | 15.6% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 14 | 14 | $840.00 | $207.09 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 383 | 826 | $206,500 | $90,724 | 43.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 262 | 895 | $255,075 | $53,799 | 21.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 245 | 271 | $176,150 | $45,379 | 25.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 126 | 424 | $159,000 | $36,797 | 23.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 132 | 132 | $66,000 | $25,352 | 38.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 32 | 39 | $17,550 | $3,494 | 19.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 56 | 57 | $8,550 | $1,401 | 16.4% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2022 | 55 | 61 | $12,200 | $1,093 | 9.0% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 16 | 16 | $5,920 | $472.80 | 8.0% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 11 | 11 | $5,500 | $441.64 | 8.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 12 | 12 | $2,700 | $429.63 | 15.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 428 | 975 | $172,875 | $106,116 | 61.4% |
About Dr. Thomas Ence, M.D
Dr. Thomas Ence, M.D is a Specialist healthcare provider based in Tarzana, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497779508.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Ence, M.D has received a total of $12,084 in payments from pharmaceutical and medical device companies, with $1,582 received in 2024. These payments were reported across 615 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($12,051).
As a Medicare-enrolled provider, Ence has provided services to 5,832 Medicare beneficiaries, totaling 12,013 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Tarzana, CA
- Active Since 07/26/2006
- Last Updated 07/09/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1497779508
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,143
- OFEV (Drug) $686.07
- STIOLTO RESPIMAT (Drug) $654.86
- TEZSPIRE (Biological) $565.05
- Prolastin-C Liquid (Biological) $489.78
- DUPIXENT (Biological) $466.72
- SYMBICORT (Drug) $430.60
- FASENRA (Biological) $393.91
- NUCALA (Biological) $380.72
- FASENRA (Drug) $337.58
- BEVESPI AEROSPHERE (Drug) $326.72
- XARELTO (Drug) $323.32
- XOLAIR (Biological) $313.55
- ELIQUIS (Drug) $271.08
- BREZTRI (Drug) $260.82
- Arikayce (Drug) $256.79
- Adempas (Drug) $227.74
- CHARTIS CATHETER (Device) $202.52
- BREO (Drug) $175.91
- STIOLTO (Drug) $171.05
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Tarzana
Zahi Nassoura, Md, MD
Specialist — Payments: $55,176
James Ong, M.d, M.D
Specialist — Payments: $28,634
Kenneth Kleinman, M.d, M.D
Specialist — Payments: $7,990
Fuad Rafidi, Md, MD
Specialist — Payments: $6,389
Dr. Aaron Shelub, M.d, M.D
Specialist — Payments: $5,666
Nicholas Panagiotis, M.d, M.D
Specialist — Payments: $3,547